Here, too, there was an indication of superior protection from CIN with pegfilgrastim than with current practice G-CSF use; however, as this was a non-randomized study, this finding must be interpreted with caution. The gene discussed is CSF3; the disease is cervical squamous intraepithelial neoplasia.